We are live on
!
Find out more
TAM
TFG Asset Management Portfolio holdings
AUM
$515M
1-Year Est. Return
24.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.32%
1 Year Est. Return
+24.47%
3 Year Est. Return
+54.92%
5 Year Est. Return
+65.34%
10 Year Est. Return
+105.07%
AUM
$748M
AUM Growth
+$127M
(+20%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-17.43%
Top 10 Holdings %
Top 10 Hldgs %
83.35%
Holding
46
New
9
Increased
13
Reduced
9
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$38.2M |
| 2 |
MBX
MBX Biosciences
MBX
|
+$2.38M |
| 3 |
Alkermes
ALKS
|
+$2.09M |
| 4 |
ABVX
Abivax
ABVX
|
+$1.84M |
| 5 |
Arrowhead Research
ARWR
|
+$1.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tarsus Pharmaceuticals
TARS
|
+$6.15M |
| 2 |
Relay Therapeutics
RLAY
|
+$1.81M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
+$1.78M |
| 4 |
Annexon
ANNX
|
+$1.73M |
| 5 |
Keros Therapeutics
KROS
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.58% |
| 2 | Healthcare | 11.03% |
| 3 | Energy | 5.54% |
| 4 | Materials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cameco
CCJ
$39.1B
| $1.34M | 0.18% |
16,015
-3,265
| -17% | -$253K |
|
|
27
Relay Therapeutics
RLAY
$4.09B
| $1.16M | 0.16% |
223,123
-475,877
| -68% | -$1.81M |
|
|
FOLD
28
DELISTED
Amicus Therapeutics
FOLD
| $955K | 0.13% |
+121,212
| New | +$863K |
|
29
Krystal Biotech
KRYS
$9.25B
| $860K | 0.12% |
+4,870
| New | +$729K |
|
30
Teck Resources
TECK
$29.5B
| $793K | 0.11% |
18,068
+11,700
| +184% | +$425K |
|
|
31
Keros Therapeutics
KROS
$200M
| $680K | 0.09% |
43,000
-85,000
| -66% | -$1.26M |
|
|
LAR
32
Lithium Argentina AG
LAR
$1.02B
| $668K | 0.09% |
+200,000
| New | +$605K |
|
33
Ultragenyx Pharmaceutical
RARE
$2.46B
| $533K | 0.07% |
+17,718
| New | +$531K |
|
|
WBI
34
WaterBridge Infrastructure LLC
WBI
$1.59B
| $504K | 0.07% |
+20,000
| New | +$469K |
|
35
NexGen Energy
NXE
$6.33B
| $376K | 0.05% |
+42,000
| New | +$310K |
|
36
Diana Shipping Inc Warrants exp 2026
DSX.WS
$5.75M
| $22.8K | ﹤0.01% |
233,400
-67,800
| -23% | -$6.84K |
|
|
SONDW
37
DELISTED
Sonder Holdings Inc Warrants
SONDW
| $204 | ﹤0.01% |
18,898
| – | – |
|
38
Sociedad Química y Minera de Chile
SQM
$19.1B
| – | – |
-7,700
| Closed | -$272K |
|
|
YARW
39
Yarrow Bioscience, Inc. Common Stock
YARW
$22.4M
| – | – |
-2,308
| Closed | -$190K |
|
Similar funds
VPP
WAM
PDIP
AGC
SC
HW
RCI
AAM
TFG Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, TFG Asset Management held 46 positions worth $748M, up 20% from $621M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
TFG Asset Management withdrew a net $130M in Q3 2025, closing 2 positions and reducing 9 holdings. Its most notable exit was Sociedad Química y Minera de Chile, an estimated $272K position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Energy.
Against the trend, TFG Asset Management opened a new position in MBX Biosciences worth $3.11M.
- TFG Asset Management's largest Q3 2025 buy was MBX Biosciences: 177,840 shares worth $3.11M.
- TFG Asset Management added most to UiPath in Q3 2025, an estimated $38.2M increase.
- TFG Asset Management's biggest Q3 2025 reduction was Tarsus Pharmaceuticals, cutting an estimated $6.15M.
- TFG Asset Management fully exited Sociedad Química y Minera de Chile in Q3 2025, selling an estimated $272K.
- TFG Asset Management's ten largest holdings make up 83% of its $748M portfolio in Q3 2025.
- TFG Asset Management opened 9 new positions and closed 2 in Q3 2025.
- TFG Asset Management's portfolio value rose 20% quarter-over-quarter to $748M.
Based on TFG Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.